PL2117563T3 - Zastosowanie antybiotyków amidynoantracyklinowych do leczenia infekcji wirusowych - Google Patents
Zastosowanie antybiotyków amidynoantracyklinowych do leczenia infekcji wirusowychInfo
- Publication number
- PL2117563T3 PL2117563T3 PL08712676T PL08712676T PL2117563T3 PL 2117563 T3 PL2117563 T3 PL 2117563T3 PL 08712676 T PL08712676 T PL 08712676T PL 08712676 T PL08712676 T PL 08712676T PL 2117563 T3 PL2117563 T3 PL 2117563T3
- Authority
- PL
- Poland
- Prior art keywords
- amidinoanthracycline
- antibiotics
- treatment
- viral infections
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL381714A PL381714A1 (pl) | 2007-02-07 | 2007-02-07 | Nowe zastosowanie medyczne pochodnych antybiotyków antracyklinowych |
EP08712676A EP2117563B1 (en) | 2007-02-07 | 2008-02-07 | Amidinoanthracycline antibiotics for use in the treatment of viral infections |
PCT/PL2008/000010 WO2008097112A1 (en) | 2007-02-07 | 2008-02-07 | Amidinoanthracycline antibiotics for use in the treatment of viral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2117563T3 true PL2117563T3 (pl) | 2013-07-31 |
Family
ID=39277274
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL381714A PL381714A1 (pl) | 2007-02-07 | 2007-02-07 | Nowe zastosowanie medyczne pochodnych antybiotyków antracyklinowych |
PL08712676T PL2117563T3 (pl) | 2007-02-07 | 2008-02-07 | Zastosowanie antybiotyków amidynoantracyklinowych do leczenia infekcji wirusowych |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL381714A PL381714A1 (pl) | 2007-02-07 | 2007-02-07 | Nowe zastosowanie medyczne pochodnych antybiotyków antracyklinowych |
Country Status (4)
Country | Link |
---|---|
US (1) | US20090298786A1 (pl) |
EP (1) | EP2117563B1 (pl) |
PL (2) | PL381714A1 (pl) |
WO (1) | WO2008097112A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732293B (zh) * | 2008-11-21 | 2012-05-23 | 上海医药工业研究院 | 9,10-蒽醌类化合物的应用 |
CN104098627B (zh) * | 2014-07-31 | 2017-04-12 | 大连大学 | 一类n‑三氟乙酰表柔红霉素的硒代衍生物,其制备方法及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL186762B1 (pl) * | 1997-10-22 | 2004-02-27 | Inst Biotechnologii I Antybiot | Nowe pochodne daunomycyny, sposób ich wytwarzania oraz zawierający je środek farmaceutyczny |
WO2007075092A1 (en) * | 2005-12-29 | 2007-07-05 | Instytut Biochemii I Biofizyki | New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs |
WO2007075094A1 (en) * | 2005-12-27 | 2007-07-05 | Instytut Biochemii I Biofizyki | New derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs |
-
2007
- 2007-02-07 PL PL381714A patent/PL381714A1/pl not_active Application Discontinuation
-
2008
- 2008-02-07 WO PCT/PL2008/000010 patent/WO2008097112A1/en active Application Filing
- 2008-02-07 EP EP08712676A patent/EP2117563B1/en not_active Not-in-force
- 2008-02-07 PL PL08712676T patent/PL2117563T3/pl unknown
-
2009
- 2009-08-07 US US12/537,270 patent/US20090298786A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090298786A1 (en) | 2009-12-03 |
WO2008097112B1 (en) | 2008-10-23 |
PL381714A1 (pl) | 2008-08-18 |
WO2008097112A1 (en) | 2008-08-14 |
EP2117563A1 (en) | 2009-11-18 |
EP2117563B1 (en) | 2012-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL250858A0 (en) | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections | |
EP1951272A4 (en) | USE OF LACTOBACILLUS FOR THE TREATMENT OF VIRAL INFECTIONS | |
HK1156038A1 (en) | Compounds and pharmaceutical compositions for the treatment of viral infections | |
IL213070A0 (en) | Methods for the treatment of infections and tumors | |
RS56870B1 (sr) | Pirolopirimidinski derivati za primenu u lečenju virusnih infekcija | |
EP2273989A4 (en) | POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
HK1134679A1 (zh) | 用於治療感染的組合物和方法 | |
ZA201000980B (en) | Reduction of concomitant infections in pigs by the use of pcv2 antigen | |
IL200116A0 (en) | Compounds and pharmaceutical compositions for the treatment of viral infections | |
PT2142186E (pt) | Utilização de oligómeros de ácido láctico no tratamento de infeções ginecológicas | |
IL195272A0 (en) | Methods and compositions for the treatment of viral infections | |
HK1144794A1 (en) | Devices for treatment of viral infections | |
ZA200802934B (en) | Use of lactobacillus for treatment of virus infections | |
SI2200600T1 (sl) | Nerameksan za uporabo pri zdravljenju subakutnegatinitusa | |
GB2411354B (en) | Use of Scutellaria for the treatment of viral infections | |
EP2217573A4 (en) | TREATMENT AND PREVENTION OF VIRUS INFECTIONS | |
ZA200904068B (en) | Anti-tsg101 antibodies and their uses for treatment of viral infections | |
PL2117563T3 (pl) | Zastosowanie antybiotyków amidynoantracyklinowych do leczenia infekcji wirusowych | |
ZA201100468B (en) | The treatment of helminthic infections | |
IL219444A (en) | Procine for use in the treatment of blood cell infections | |
SI2155758T1 (sl) | Tetrahidrofuro(3,4-d)dioksolanske spojine za uporabo pri zdravljenju virusnih infekcij in raka | |
ZA200800201B (en) | Composition and the use thereof for the treatment of viral infections | |
GB0605035D0 (en) | Improvements In Or Relating To The Treatment Of Orthopaedic Infections |